论文部分内容阅读
目的:探讨补肾助孕方联合促排卵药对排卵障碍性不孕患者的影响,以期为临床提供有据可循的诊治依据。方法:将90例患者随机分为中药治疗组、西药治疗组、中西医结合治疗组。3组用药期间分别检测患者卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E_2)及内膜厚度。结果:月经第3天,中西医结合治疗组治疗后较治疗前及中药治疗组、西药治疗组基础血LH、E_2显著改善(P<0.05);卵泡优势时,中西医结合治疗组治疗后较治疗前及中药治疗组、西药治疗组血FSH、LH显著改善(P<0.05);中西医结合治疗组治疗后子宫内膜厚度(8.04±1.35)mm较中药组治疗后(6.88±1.61)mm,西药组治疗后(6.78±1.54)mm显著增厚(P<0.05)。结论:补肾助孕方结合促排卵药明显改善排卵障碍性不孕症患者的临床症状,为排卵障碍性不孕患者带来了更多的治疗契机。
Objective: To investigate the effect of invigorating the kidney and promoting pregnancy on the ovulation disorder infertility patients in order to provide a basis for clinical diagnosis and treatment. Methods: 90 patients were randomly divided into traditional Chinese medicine treatment group, Western medicine treatment group, Integrative Medicine group. The levels of FSH, LH, E2 and intima were measured in the three groups. Results: On the third day after menstruation, the levels of LH and E_2 in the Chinese medicine group and western medicine group were significantly improved after treatment (P <0.05), while those in the combination of traditional Chinese medicine and western medicine treatment group were significantly lower than those before treatment The levels of FSH and LH in the treatment group and the western medicine group were significantly improved (P <0.05) before and after the treatment with traditional Chinese medicine (WM) group (8.04 ± 1.35) mm compared with those in the traditional Chinese medicine group (6.88 ± 1.61) mm (6.78 ± 1.54) mm in the Western medicine group were significantly increased (P <0.05). Conclusion: Bushenzhuye decoction combined with ovulation drugs significantly improve the clinical symptoms of patients with ovulatory dysmorphic infertility, which brings more opportunities for treatment of patients with ovulatory disorder infertility.